tradingkey.logo
tradingkey.logo
Search

Brainsway Ltd

BWAY
Add to Watchlist
15.190USD
-0.100-0.65%
Close 07/02, 13:00ETQuotes delayed by 15 min
594.93MMarket Cap
33.12P/E TTM

TradingKey Stock Score of Brainsway Ltd

Currency: USD Updated: 2026-07-02

Key Insights

Brainsway Ltd's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 77 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 17.50.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Brainsway Ltd's Score

Industry at a Glance

Industry Ranking
77 / 204
Overall Ranking
182 / 4565
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Brainsway Ltd Highlights

StrengthsRisks
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 64.31% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 52.23M.
Fairly Valued
The company’s latest PE is 33.12, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 12.27M shares, decreasing 20.62% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 82.90K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.12.

Analyst Rating

Based on 2 analysts
Strong Buy
Current Rating
17.500
Target Price
+14.45%
Upside Space

FAQs

How does TradingKey generate the Stock Score of Brainsway Ltd?

The TradingKey Stock Score provides a comprehensive assessment of Brainsway Ltd based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Brainsway Ltd’s performance and outlook.

How do we generate the financial health score of Brainsway Ltd?

To generate the financial health score of Brainsway Ltd, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Brainsway Ltd's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Brainsway Ltd.

How do we generate the company valuation score of Brainsway Ltd?

To generate the company valuation score of Brainsway Ltd, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Brainsway Ltd’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Brainsway Ltd’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Brainsway Ltd.

How do we generate the earnings forecast score of Brainsway Ltd?

To calculate the earnings forecast score of Brainsway Ltd, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Brainsway Ltd’s future.

How do we generate the price momentum score of Brainsway Ltd?

When generating the price momentum score for Brainsway Ltd, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Brainsway Ltd’s prices. A higher score indicates a more stable short-term price trend for Brainsway Ltd.

How do we generate the institutional confidence score of Brainsway Ltd?

To generate the institutional confidence score of Brainsway Ltd, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Brainsway Ltd’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Brainsway Ltd.

How do we generate the risk management score of Brainsway Ltd?

To assess the risk management score of Brainsway Ltd, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Brainsway Ltd’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Brainsway Ltd.